Testing a new drug for safety in healthy adults
Part of Immune system & allergy, Skin clinical trials.
This study tests a new investigational drug called ISH0613 in healthy volunteers to see if it is safe and how the body processes it. It is the first time this drug is given to humans.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy adult of Chinese ethnicity, aged 18 to 45.
- Your body mass index (BMI) must be between 19 and 28.
- You must agree to use effective birth control during the study and not donate sperm or eggs.
- You must not have significant medical conditions, allergies to the drug, or recent infections.
- You must avoid alcohol, smoking, caffeine, certain medications, and vaccines for a period before and during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new injection for the first time in healthy volunteers to see how safe it is and how the body handles it. It may help determine if the drug is suitable for future patients.
This trial tests a new medicine (called 627) in healthy adults to see if it is safe and how the body handles it. It may help future treatment development.
This study tests a single dose of a new medication called SYH2061 to see if it is safe and how the body processes it. It is for healthy adults aged 18 to 55 who have had certain vaccines and are willing to follow study rules.
This study tests a single dose of a new drug called SHR-7012 in healthy volunteers to check if it is safe and how the body handles it. It is a first-in-human trial, so participants will be closely monitored.
This study tests a new investigational medicine in healthy adults to see how safe it is and how the body processes it. It is a first-in-human trial, so it is looking for volunteers who are generally well and have normal immune function.
This study tests a new investigational medicine called SSS67, given as a one-time IV infusion. It is an early-phase trial in healthy volunteers to check how safe the drug is and how the body handles it, and it may help researchers decide if it can be developed for future conditions.
Hear when a new SLE (Systemic Lupus) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.